298380.KQ
ABL Bio Inc.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 67,600.00
−2.45%Latest reported
- Last report date
- May 11, 2026
- EPS actual
- -KRW 261
- EPS estimate
- —
- Revenue actual
- KRW 13.1B
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 11, 2026